The global rare hemophilia factors market is poised for substantial expansion, with projections indicating a market size of USD 490.4 million by the year 2030. This growth is expected to occur at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2030, as detailed in a recent report by Grand View Research, Inc. A significant impetus for this market growth is the increasing...